Advantages of Fast-Acting ADP Receptor Blockade in Ischemic Heart Disease

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/01.atv.0000053387.06709.32
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Role of Short-Acting Nitroglycerin in the Management of Ischemic Heart Disease

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Ischemic Heart Disease.

Japanese Journal of Geriatrics
GerontologyGeriatrics
1998English

Apoptosis in Ischemic Heart Disease

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

-Adrenergic Receptor Blockade in Chronic Heart Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Perfusion Cardiovascular Magnetic Resonance in a Child With Ischemic Heart Disease: Potential Advantages Over Nuclear Medicine

Circulation
Cardiovascular MedicinePhysiologyCardiology
2010English

Association Between Depression, Pressure Pain Sensitivity, Stress and Autonomous Nervous System Function in Stable Ischemic Heart Disease: Impact of Beta-Adrenergic Receptor Blockade

Journal of Behavioral and Brain Science
2016English

Peroxynitrite - Matrix Metalloproteinase and Erythropoietin Receptor Signaling Pathways in Ischemic Heart Disease

English

MRI of Ischemic Heart Disease

Nippon Hoshasen Gijutsu Gakkai zasshi
Medicine
2001English

Coagulation Factors in Ischemic Heart Disease

Circulation. Genomic and precision medicine
GeneticsCardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy